IPO of Lumos Diagnostics Holdings Limited

$$BDO.LiveSite.Deals.DealType$$Capital markets
$$BDO.LiveSite.Deals.Industry$$Healthcare & Manufacturing & Professional Services
$$BDO.LiveSite.Deals.ClientName$$Lumos Diagnostics Holdings Limited

In July 2021, Lumos Diagnostics Holdings Limited (LDX) raised A$38m in primary capital and listed on the Australian Securities Exchange.

Lumos is a fully integrated developer and manufacturer of rapid, point-of-care (POC) diagnostic solutions with corporate headquarters in Melbourne, and manufacturing facilities in California and Florida in the United States.

Lumos develops and manufactures proprietary and in-licensed POC diagnostic tests for commercial sale through distributors under its Products division, and develops and manufactures POC diagnostic tests on behalf of clients under fee-based commercial contracts under its Commercial Services division.

Led by Sebastian Stevens, National Leader Private Equity and Marcus Leonard, Partner Tax, BDO was engaged to perform the Independent Accountant and Independent Tax Adviser role for Lumos’ IPO.

Lumos engaged BDO Corporate Finance and Tax teams for the company’s listing on the Australian Securities Exchange (ASX). BDO’s ASX listing and U.S. cross-border experience, high quality service and commitment was evident throughout the process. The BDO team was instrumental in ensuring a successful ASX listing and I would strongly recommend BDO to any Company about to embark on the ASX listing process.